Médicaments rhumatologiques pour le traitement de l’infection par le COVID-19

[Article in French]

Affiliations

¹ Rheumatology Unit, Azienda Sanitaria USL-Toscana Centro, Hospital S. Giovanni di Dio, Via Torregalli 3, 50143 Florence, Italy.
² Immunology and Allergology Laboratory Hospital S.Giovanni di Dio, Azienda USL-Toscana Centro, Florence, Italy.
³ Clinic of Rheumatology, Department of Medicine (DAME), ASUFC, Udine, Italy.

Editorial

[Article in French]

Maurizio Benucci et al. Rev Rhum Ed Fr. 2020 May.

. 2020 May;87(3):150-152.

doi: 10.1016/j.rhum.2020.03.010. Epub 2020 Apr 24.

¹ Rheumatology Unit, Azienda Sanitaria USL-Toscana Centro, Hospital S. Giovanni di Dio, Via Torregalli 3, 50143 Florence, Italy.
² Immunology and Allergology Laboratory Hospital S.Giovanni di Dio, Azienda USL-Toscana Centro, Florence, Italy.
³ Clinic of Rheumatology, Department of Medicine (DAME), ASUFC, Udine, Italy.

No abstract available

Comment on

Old and new antirheumatic drugs for the treatment of COVID-19.
Benucci M, Damiani A, Infantino M, Manfredi M, Quartuccio L. Benucci M, et al. Joint Bone Spine. 2020 May;87(3):195-197. doi: 10.1016/j.jbspin.2020.03.013. Joint Bone Spine. 2020. PMID: 32321635 Free PMC article. No abstract available.

1. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re.... Accessed March 12, 2020.
1. Channappanavar R., Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39:529–539. - PMC - PubMed
1. Ji W., Wang W., Zhao X. Cross-species transmission of the newly identified coronavirus 2019-nCoV. J Med Virol. 2020;92:433–440. - PMC - PubMed
1. Zhao Y., Zhao Z., Wang Y. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. BioRxiv. 2020 doi: 10.1101/2020.01.26.919985. - DOI
1. Huang C., Wang Y., Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. - PMC - PubMed